Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Current state and clinical outcome in Turkish patients with hepatocellular carcinoma.

Ekinci O, Baran B, Ormeci AC, Soyer OM, Gokturk S, Evirgen S, Poyanli A, Gulluoglu M, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S.

World J Hepatol. 2018 Jan 27;10(1):51-61. doi: 10.4254/wjh.v10.i1.51.

2.

Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study.

Soyer OM, Baran B, Ormeci AC, Sahin D, Gokturk S, Evirgen S, Basar R, Firat P, Akyuz F, Demir K, Besisik F, Kaymakoglu S, Karaca C.

Medicine (Baltimore). 2017 Jan;96(1):e5513. doi: 10.1097/MD.0000000000005513.

3.

Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.

Iliaz R, Akyuz U, Tekin D, Serilmez M, Evirgen S, Cavus B, Soydinc H, Duranyildiz D, Karaca C, Demir K, Besisik F, Kaymakoglu S, Akyuz F.

Arab J Gastroenterol. 2016 Dec;17(4):164-167. doi: 10.1016/j.ajg.2016.10.002.

PMID:
27916547
4.

Belching in Irritable Bowel Syndrome: An Impedance Study.

Obekli T, Akyuz F, Akyuz U, Arici S, İliaz R, Gokturk S, Evirgen S, Cavus B, Karaca C, Demir K, Besisik F, Kaymakoglu S.

J Neurogastroenterol Motil. 2017 Jul 30;23(3):409-414. doi: 10.5056/jnm16103.

5.

Retention during capsule endoscopy: Is it a real problem in routine practice?

Ormeci AC, Akyuz F, Baran B, Gokturk S, Ormeci T, Pinarbasi B, Mutluay Soyer O, Evirgen S, Akyuz U, Karaca C, Demir K, Kaymakoglu S, Besisik F.

J Int Med Res. 2016 Aug;44(4):968-75. doi: 10.1177/0300060516645420. Epub 2016 Jul 4.

6.

Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

Ormeci A, Emrence Z, Baran B, Soyer OM, Gokturk S, Evirgen S, Akyuz F, Karaca C, Besisik F, Kaymakoglu S, Ustek D, Demir K.

Eur Rev Med Pharmacol Sci. 2016 May;20(9):1795-7.

7.

What is the impact of capsule endoscopy in the long term period?

Ormeci A, Akyuz F, Baran B, Gokturk S, Ormeci T, Pinarbasi B, Soyer OM, Evirgen S, Akyuz U, Karaca C, Demir K, Kaymakoglu S, Besisik F.

World J Gastrointest Endosc. 2016 Apr 10;8(7):344-8. doi: 10.4253/wjge.v8.i7.344.

8.

Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.

Ormeci A, Emrence Z, Baran B, Gokturk S, Soyer OM, Evirgen S, Akyuz F, Karaca C, Besisik F, Kaymakoglu S, Ustek D, Demir K.

Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):879-85.

9.

Review on the applications of ultrasonography in dentomaxillofacial region.

Evirgen Ş, Kamburoğlu K.

World J Radiol. 2016 Jan 28;8(1):50-8. doi: 10.4329/wjr.v8.i1.50. Review.

10.

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Akyuz F, Karaca C, Demir K, Besisik F, Onel D, Gulluoglu M, Badur S, Kaymakoglu S.

Liver Int. 2015 Oct;35(10):2265-74. doi: 10.1111/liv.12831. Epub 2015 Apr 17.

PMID:
25800974
11.

Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening.

Demir A, Akyüz F, Göktürk S, Evirgen S, Akyüz U, Örmeci A, Soyer Ö, Karaca C, Demir K, Gundogdu G, Güllüoğlu M, Erer B, Kamalı S, Kaymakoglu S, Besisik F, Gül A.

Scand J Gastroenterol. 2014 Dec;49(12):1414-8. doi: 10.3109/00365521.2014.976838. Epub 2014 Nov 5.

PMID:
25369738
12.

Volatile sulphur compound levels and related factors in patients with chronic renal failure.

Gulsahi A, Evirgen S, Öztaş B, Genç Y, Çetinel Y.

J Clin Periodontol. 2014 Aug;41(8):814-9. doi: 10.1111/jcpe.12280. Epub 2014 Jul 7.

PMID:
24923904
13.

Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.

Yilmaz E, Baran B, Soyer OM, Onel M, Onel D, Ormeci AC, Gokturk S, Evirgen S, Akyuz F, Demir K, Besisik F, Kaymakoglu S, Karaca C.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1753-8. doi: 10.1016/j.cgh.2014.01.043. Epub 2014 Feb 26.

PMID:
24582569
14.

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.

Baran B, Gulluoglu M, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Yesil S, Akyuz F, Karaca C, Demir K, Kaymakoglu S, Besisik F.

J Viral Hepat. 2014 Feb;21(2):111-20. doi: 10.1111/jvh.12127. Epub 2013 Aug 27.

PMID:
24383924
15.

Effects of tongue coating and oral health on halitosis among dental students.

Evirgen S, Kamburoğlu K.

Oral Health Prev Dent. 2013;11(2):169-73. doi: 10.3290/j.ohpd.a29361.

PMID:
23534037
16.

Effect of clinician's experience, age, gender and calibration on the assessment of halitosis.

Evirgen S, Kamburoğlu K, Gulsahi A.

Oral Health Prev Dent. 2013;11(1):17-22. doi: 10.3290/j.ohpd.a29371.

PMID:
23507677
17.

Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Bozbey HU, Akyuz F, Karaca C, Demir K, Besisik F, Onel D, Gulluoglu M, Badur S, Kaymakoglu S.

Antimicrob Agents Chemother. 2013 Apr;57(4):1790-6. doi: 10.1128/AAC.02600-12. Epub 2013 Feb 4.

18.

Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of response.

Karaca C, Soyer OM, Baran B, Ormeci AC, Gokturk S, Aydin E, Evirgen S, Akyuz F, Demir K, Besisik F, Kaymakoglu S.

Antivir Ther. 2013;18(4):561-6. doi: 10.3851/IMP2381. Epub 2012 Sep 14.

PMID:
22976528
19.

Delayed diagnosis of oral squamous cell carcinoma: a case series.

Akbulut N, Oztas B, Kursun S, Evirgen S.

J Med Case Rep. 2011 Jul 6;5:291. doi: 10.1186/1752-1947-5-291.

20.

Dental anomalies in individuals with cleft lip and/or palate.

Akcam MO, Evirgen S, Uslu O, Memikoğlu UT.

Eur J Orthod. 2010 Apr;32(2):207-13. doi: 10.1093/ejo/cjp156.

PMID:
20335565

Supplemental Content

Loading ...
Support Center